TickerFacts.

NeuroPace Inc (NPCE): Revenue

Annual figures by period end, from SEC filings.

$99.99M
Year ended 2025-12-31
+30.0%
3-year compound annual growth
+19.4%
5-year compound annual growth
2020-12-31: $41.14M2021-12-31: $45.18M2022-12-31: $45.52M2023-12-31: $65.42M2024-12-31: $79.91M2025-12-31: $99.99M$99.99M
2020-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$99.99M+25.1%2026-03-03, From 2025-01-01
2024-12-31$79.91M+22.1%2026-03-03, From 2024-01-01
2023-12-31$65.42M+43.7%2025-03-04, From 2023-01-01
2022-12-31$45.52M+0.7%2024-03-05, From 2022-01-01
2021-12-31$45.18M+9.8%2023-03-02, From 2021-01-01
2020-12-31$41.14Mn/a2022-03-10, From 2020-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
NeuroPace Inc (NPCE)2025-12-31$99.99M+25.1%
Beta Bionics, Inc. (BBNX)2025-12-31$100.25M+53.9%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$95.13M+59.0%
Pulmonx Corp (LUNG)2025-12-31$90.50M+8.0%
Anika Therapeutics, Inc. (ANIK)2025-12-31$112.82M-5.9%
Orasure Technologies Inc (OSUR)2025-12-31$115.02M-38.1%
Delcath Systems, Inc. (DCTH)2025-12-31$85.23M+129.1%
Iradimed Corp (IRMD)2025-12-31$83.81M+14.4%
TELA Bio, Inc. (TELA)2025-12-31$80.28M+15.8%

Compare NPCE, BBNX, KMTS, LUNG side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗